Ophthalmic Steroids Drugs Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2024 February 15
SKU : PH3618
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
Who are the Major key players in Ophthalmic Steroids Drugs Market ?
Bausch & Lomb Inc., Alimera Sciences, Allergan, Inc., Novartis AG, GlaxoSmithKline plc, Genentech, Inc., Pfizer Inc., Bayer AG, Regeneron Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc. Shanghai Pharmaceutical Group Co., Ltd., China Resources Pharmaceutical GroupCo., Ltd. and Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd.
Which region is the largest market for Ophthalmic Steroids Drugs?
North America is the largest market for Ophthalmic Steroids Drugs, due to the high healthcare infrastructure, consumer awareness, and incidence of intraocular disorders.
Related Reports
pharmaceuticalsOphthalmology Drugs and Devices Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 22
Starting from
$4350
medical-devicesOphthalmic Viscoelastic Devices (OVD) Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 06
Starting from
$4350
medical-devicesOphthalmic Lasers Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 April 12
Starting from
$4350
pharmaceuticalsAndrogens and Anabolic Steroids Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 March 04
Starting from
$4350
medical-devicesOphthalmic Devices Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 April 01
Starting from
$4350
medical-devicesOphthalmic Diagnostic Equipment Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 March 27
Starting from
$4350